Company intelligence / Profile preview

Lunan Better Pharmaceutical Co., Ltd.

Ownership: Private
Employees: ~5000
Development stage: Commercial

Overview

Lunan Better Pharmaceutical has multiple approved products including Epirubicin Hydrochloride for injection, Isoflurane for inhalation, and Milrinone injection which is USFDA approved[1]. The company has several drugs that have received approval in various countries including Japan and the United States[2].

Therapeutic areas: PulmonologyDermatologyCardiovascularNephrologyInfectious Diseases
Modalities: Small molecule drugsChemical drugs
Industry: Pharma

Drug pipeline

1 asset

Isosorbide oral solution

Partnerships

Adcoris Biopharma Co., LTD. (strategic collaboration agreement for ADC product co-development)[9][10]

Beyond the preview

Go deeper on Lunan Better Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lunan Better Pharmaceutical Co., Ltd..

Explore the full profile